Wird geladen...
Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma
A differentiation antigen commonly expressed on melanoma cells, gp100 is the target of infiltrating T cells. We conducted a phase I randomized cross-over trial of melanoma patients with either xenogeneic (mouse) or human gp100 plasmid DNA injected intramuscularly at three dosages (100, 500 or 1,500 ...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Artigo |
Sprache: | Inglês |
Veröffentlicht: |
Academy
of Cancer Immunology
2009
|
Schlagworte: | |
Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2888533/ https://ncbi.nlm.nih.gov/pubmed/19496531 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|